Document Detail

Ventricular arrhythmias and sudden cardiac death.
MedLine Citation:
PMID:  23101719     Owner:  NLM     Status:  In-Data-Review    
Management strategies for ventricular arrhythmias are guided by the risk of sudden death and severity of symptoms. Patients with a substantial risk of sudden death usually need an implantable cardioverter defibrillator (ICD). Although ICDs effectively end most episodes of ventricular tachycardia or ventricular fibrillation and decrease mortality in specific populations of patients, they have inherent risks and limitations. Generally, antiarrhythmic drugs do not provide sufficient protection from sudden death, but do have a role in reducing arrhythmias that cause symptoms. Catheter ablation is likewise important for reducing the frequency of spontaneous arrhythmias and is curative for some patients, usually those with idiopathic arrhythmias and no heart disease. Arrhythmia surgery is now infrequent, offered by only a few specialised centres for refractory arrhythmias. Advances in understanding of genetic arrhythmia syndromes and in technology for mapping and ablation of ventricular arrhythmias, and enhanced algorithms in implantable devices for rhythm management, have contributed to improved outcomes.
Roy M John; Usha B Tedrow; Bruce A Koplan; Christine M Albert; Laurence M Epstein; Michael O Sweeney; Amy Leigh Miller; Gregory F Michaud; William G Stevenson
Related Documents :
11218149 - Time-dependent diagnostic performance of a rapid troponin t version 2 bedside test in p...
17618829 - Biomarkers of cardiovascular damage and dysfunction--an overview.
21392609 - The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovasc...
21267579 - Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemi...
17021759 - Fractures of the sternum: the influence of non-invasive cardiac monitoring on management.
21450719 - Cardiac resynchronization therapy in paediatric and congenital heart disease patients.
15900559 - Stent-based delivery of abt-578 via a phosphorylcholine surface coating reduces neointi...
10229739 - Lack of correlation between pattern of collateralization and misery perfusion in patien...
1223829 - Free adrenaline, noradrenaline and vanilylmandelic acid excretion with 24-hour urine in...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Lancet     Volume:  380     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  1520-9     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Department of Medicine, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Catheter ablation of atrial arrhythmias: state of the art.
Next Document:  The Narcissistic Personality Inventory: A Useful Tool for Assessing Pathological Narcissism? Evidenc...